The Asia-Pacific Programmable Infusion Pumps Market is expected to grow at a strong CAGR of 9% during the forecast period (2023-2030). The increasing healthcare expenditure in the region is the major reason for the market growth of Programmable Infusion Pumps in the Asia-Pacific.The Asia Pacific region is a significant market for medical devices, including infusion pumps. The demand for infusion pumps in the region has been driven by factors such as an increasing aging population and the rising prevalence of chronic diseases. For instance, as per the Globocan 2020, 1028658 new cancer cases were registered in Japan in 2020 and 420124 people died because of the disease in the same year. Further, the rising awareness about advanced medical technology is also the major factor driving the growth of programmable infusion pumps in the region.

Access sample report (including graphs, charts, and figures): https://univdatos.com/reports/programmable-infusion-pumps-market?popup=report-enquiry

Based on modality, the market is segmented into portable and stationary. As per our analysis, the stationary infusion pumps segment held a dominant share in 2022. Stationary infusion pumps are designed to be used in a fixed location, such as a hospital or clinic, and are typically larger and more complex. The increasing hospitalization and high usage of stationary infusion pumps in clinics and hospitals is the major attributing factor for the dominating share of the segment.

Based on the application, the market is segmented into oncology, pediatrics, pain, diabetes, and others. The cardiovascular and metabolic disorders segment is expected to grow with a higher CAGR in the programmable infusion pumps market during the forecast period. The Pain Programmable Infusion Pumps Market is driven by a number of factors, including an increase in the incidence of chronic pain conditions, advances in medical technology, and the growing demand for home healthcare. Additionally, the increasing use of remote patient monitoring and the availability of reimbursement for pain-programmable infusion pumps are also expected to drive the growth of the market.

Based on end-users, the market is segmented into hospitals, ambulatory surgical centers, homecare settings, and others. As per our analysis, the hospital's segment held a dominant share in 2022. The growth of the hospital segment is being driven by the increasing adoption of digital health technologies, the growing demand for remote monitoring solutions, and the need for more efficient and cost-effective healthcare.

Global Programmable Infusion Pumps Market Segmentation

Market Insight, by Modality

·       Portable

·       Stationary

Market Insight, by Application

·       Oncology

·       Pediatrics

·       Pain

·       Diabetes

·       Others

Click here to view the Report Description & TOC: https://univdatos.com/reports/programmable-infusion-pumps-market

Market Insight, by End-Users

·       Hospitals

·       Ambulatory Surgical Centers

·       Homecare Settings

·       Others

Market Insight, by Region

·       North America

o   U.S.

o   Canada

o   Rest of North America

·       Europe

o  Germany

o  UK

o  France

o  Italy

o  Spain

o  Rest of Europe

·       APAC

o  China

o  Japan

o  India

o  Rest of APAC

·       Rest of the World 

Top Company Profiles

·       ICU Medical, Inc

·       Smiths Group plc

·       Baxter

·       Fresenius Medical Care

·       Johnson & Johnson Private Limited

·       Medtronic

·       BD

·       Terumo Corporation

·       B. Braun SE

·       Moog Inc.

Contact Us:

UnivDatos

Contact Number - +1 978 733 0253

Email - contact@univdatos.com 

Website - www.univdatos.com

Linkedin- https://www.linkedin.com/company/univ-datos-market-insight/mycompany/